Fundraising Fox

Mukesh Kumar

Investor

Regulatory Advisor at 2Flo Ventures · Director of Regulatory Affairs at ResQ Pharma

Gaithersburg, Maryland, United States

Find your path to Mukesh

407 people in our graph share verified history with Mukesh — schools, employers, funds. One of them is your warm intro.

Uri LopatinunlockedMukesh: together at National Institutes of Health (2003–2004)
×2Mukesh: together at National Institutes of Health
×4Mukesh: together at Quantic School of Business and Technology
×5Mukesh: together at Delhi University

About

Mukesh Kumar is Chairman of the Board at Akan Biosciences and CEO of FDAMap. He began his career as a staff scientist at NIH focused on gene therapy, then developed expertise in intellectual property, licensing, and regulatory affairs while managing over 50 global clinical trials across 34 countries. His experience spans technology transfer, global regulatory strategy, clinical trial management, and GCP/GLP audits, with current work focused on bringing therapeutic and diagnostic products from Asia and Latin America to US and EU markets.

Director of Regulatory Affairs at ResQ Pharma

Intro paths

→

In turn, Mukesh can intro founders to ResQ Pharma's investors below.

ResQ Pharma's investors · 1

2Flo VenturesChicago · $400 – $1K checks

Co-founders at ResQ Pharma

GW
Guy WeinbergDirector, President and Secretary of Issuer
DW
Dr. WeinbergFounder and President

Experience

  1. Akan BiosciencesChairman of the Boardcurrent2017 — presentGaithersburg, MD
  2. FDA MapChief Executive Officercurrent2015 — presentGaithersburg, Maryland
  3. Montgomery County Economic Development Corporation - MarylandBoard Membercurrent2022 — presentRockville, Maryland, United States
  4. Vivacelle BioSenior Vice President, Regulatory Affairscurrent2019 — presentChicago, IL
  5. Brij Strategic ConsultationsChief Executive Officercurrent2014 — presentGaithersburg, MD
  6. George Washington UniversityAdjunct Assistant Professor, Clinical Research and Leadershipcurrent2015 — presentSchool of Medicine and Health Sciences, Washington DC
  7. GAIBPPresidentcurrent2006 — present
  8. American UniversityProfessor (Adjunct)2005 — 2021
  9. DLTA (druglifecycle.com)Chief Innovation Officer2016 — 2017Silver Spring, MD
  10. Montgomery CollegeProfessor (Adjunct), Program Director, CCPM2011 — 2016
  11. Amarex Clinical Research, LLCVice-President2014 — 2016Germantown, Maryland
  12. Amarex BioVenturesManaging Director2012 — 2016Washington D.C. Metro Area
  13. Amarex Clinical ResearchSenior Director Regulatory Affairs2006 — 2014
  14. RAPSMember, Board of Editors2006 — 2013
  15. Technical Resources International, Inc.Regulatory specialist2004 — 2006
  16. National Institutes of HealthStaff Scientist2003 — 2004
  17. National Institutes of HealthScientist1997 — 2003
  18. OTT, NIHIntern2002 — 2004

Skills & more

Biotechnology IndustryGood Manufacturing Practice (GMP)

Languages Hindi · Punjabi

From Mukesh's professional profile.

Colleagues at 2Flo Ventures

Amanda Johnson
Venture Fellow at 2Flo Ventures
Amanda Waldhauser
Executive Director at Roivant Social Ventures at 2Flo Ventures
Angela James
Senior Advisor at 2Flo Ventures
Azurii Collier
Commercial Advisor at 2Flo Ventures
Brenda Ametepe
Venture Fellow at 2Flo Ventures
Charlotte Jones-Burton
Partner at 2Flo Ventures
Christina Broomes
Commercial Advisor at 2Flo Ventures
Christopher Whitfield
Strategic Advisor at 2Flo Ventures

Frequently asked questions

Who is Mukesh Kumar?
Mukesh Kumar is Chairman of the Board at Akan Biosciences and CEO of FDAMap. He began his career as a staff scientist at NIH focused on gene therapy, then developed expertise in intellectual property, licensing, and regulatory affairs while managing over 50 global clinical trials across 34 countries. His experience spans technology transfer, global regulatory strategy, clinical trial management, and GCP/GLP audits, with current work focused on bringing therapeutic and diagnostic products from Asia and Latin America to US and EU markets.
Where does Mukesh Kumar work?
Mukesh Kumar is Regulatory Advisor at 2Flo Ventures and Director of Regulatory Affairs at ResQ Pharma.
Where did Mukesh Kumar go to school?
Mukesh Kumar studied at Quantic School of Business and Technology (Master of Business Administration - MBA); Delhi University (Ph.D., Biochemistry); National Dairy Research Institute (MS, Biochemistry).

Same school

Also attended Quantic School of Business and Technology97

Victoria BondarchukDirector at Marlin Equity PartnersHillary LehrManaging Director, Fund V at Higher Ground LabsArun IyerInvestor at Green FlagAlex RendónInvestment Associate at BuenTrip VenturesOluwatofunmi IdowuVenture Analyst at LoftyInc CapitalClaire CrowtherVice President, Strategy & Operations at Underscore VC

+ 91 more

Also attended Delhi University164

Sourabh Kumar GuptaAssociate - Corporate Development at Fireside Ventures Advisory LlpKritika KashyapEA at Fireside Ventures Advisory LlpRama KannanGeneral Partner Advisor at Beyond Capital VenturesAmrit RajPartner & Chief Marketing Officer at Jungle VenturesShunyam GuptaAnalyst, Asia at RTP GlobalAtul DhawanAudit & Strategy Mentor at SenseAI Ventures

+ 158 more

Also attended National Dairy Research Institute2

Harkesh MittalChairman, Startup India Seed Fund Committee at SeafundSaurabh PareekInvestment Director, India at Circulate Capital

Shared employers

Also worked at Akan Biosciences1

John CunninghamPartner at 2Flo Ventures

Also worked at Montgomery College1

Mustafa Al-AdhamiFounder at Astek Diagnostics

Also worked at National Institutes of Health92

Jun JeonInvestor at Khosla VenturesUri LopatinInvestor at Khosla VenturesMax ColbertPhysician-Entrepreneur at Medical Excellence CapitalLeela SrinivasanCEO, Parity at Bull City Venture PartnersVictoria GraceFounding partner of Colle Capital Partners, an opportunistic early-stage technology venture fundAshok SrinivasanChief Science Advisor at AIF

+ 86 more